Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults

AIDS Research and Human Retroviruses

Volumn 26, Issue 4, 2010, Pages 459-469

  Wong, Ambrose H W ^a,b   Williams, Katie ^a   Reddy, Sharon ^b   Wilson, Douglas ^c   Giddy, Janet ^d   Alter, Galit ^a   Ghebremichael, Musie ^e   Carrington, Mary N ^f   Ndung'U, Thumbi ^b   Walker, Bruce D ^a,b   Altfeld, Marcus ^a,b   Carr, William H ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c EDENDALE HOSPITAL   (South Africa)

^d MCCORD HOSPITAL   (South Africa)

^e HARVARD MEDICAL SCHOOL   (United States)

^f SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; NATURAL KILLER CELL RECEPTOR; PROTEIN P46; UNCLASSIFIED DRUG;

ADULT; ADULT DISEASE; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CRYOPRESERVATION; DEGRANULATION; DISEASE COURSE; DISEASE SEVERITY; FLOW CYTOMETRY; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTH AFRICA; VIRUS LOAD; VIRUS PATHOGENESIS;

ADULT; CELL DEGRANULATION; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; RECEPTORS, KIR; RECEPTORS, KIR2DL1; RECEPTORS, NATURAL KILLER CELL; SOUTH AFRICA; VIRAL LOAD; VIRULENCE;

EID: 77951807776     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0176     Document Type: Article

References (38)

1. Martin MP, Gao X, Lee JH, et al.: Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002;31(4):429-434.
2. Martin MP, Qi Y, Gao X, et al.: Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007;39(6): 733-740.
3. Alter G, Martin MP, Teigen N, et al.: Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR=HLA subtypes. J Exp Med 2007;204(12):3027-3036.
4. Fu GF, Hao S, Zhao JL, et al.: Changes in NK cell counts and receptor expressions and emergence of CD3(dim)=CD56+ cells in HIV-1 infected patients in China. Viral Immunol 2009;22(2):105-116.
5. Mavilio D, Lombardo G, Kinter A, et al.: Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 2006;203(10):2339-2350.
6. Brunetta E, Fogli M, Varchetta S, et al.: The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. Blood 2009;114(18):3822-3830.
7. Puren AJ: The HIV-1 epidemic in South Africa. Oral Dis 2002;8(Suppl 2):27-31.
8. Norman PJ, Carrington CV, Byng M, et al.: Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun 2002; 3(2):86-95.
9. Middleton D, Meenagh A, Moscoso J, and Arnaiz-Villena A: Killer immunoglobulin receptor gene and allele frequencies in Caucasoid, Oriental and Black populations from different continents. Tissue Antigens 2008;71(2):105-113.
10. Fogli M, Mavilio D, Brunetta E, et al.: Lysis of endogenously infected CD4+T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog 2008;4(7):e1000101.
11. Rousseau CM, Birditt BA, McKay AR, et al.: Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes. J Virol Methods 2006;136(1-2): 118-125.
12. Martin MP and Carrington M: KIR locus polymorphisms: Genotyping and disease association analysis. Methods Mol Biol 2008;415:49-64.
13. Cao K, Moormann AM, Lyke KE, et al.: Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 2004;63(4):293-325.
14. Honeyborne I, Rathod A, Buchli R, et al.: Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa. J Immunol 2006;176(8):4699-4705.
15. Williams F, Meenagh A, Darke C, et al.: Analysis of the distribution of HLA-B alleles in populations from five continents. Hum Immunol 2001;62(6):645-650.
16. Middleton D, Williams F, Meenagh A, et al.: Analysis of the distribution of HLA-A alleles in populations from five continents. Hum Immunol 2000;61(10):1048-1052.
17. Alter G, Malenfant JM, and Altfeld M: CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004;294(1-2):15-22. (Pubitemid 39626587)
18. Mavilio D, Benjamin J, Daucher M, et al.: Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci USA 2003;100(25):15011- 15016.
19. Alter G, Malenfant JM, Delabre RM, et al.: Increased natural killer cell activity in viremic HIV-1 infection. J Immunol 2004;173(8):5305-5311.
20. Eller MA, Eller LA, Ouma BJ, et al.: Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection. J Acquir Immune Defic Syndr 2009;51(4):380-389.
21. Fogli M, Costa P, Murdaca G, et al.: Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur J Immunol 2004;34(8):2313-2321.
22. Litwin V, Gumperz J, Parham P, Phillips JH, and Lanier LL: Specificity of HLA class I antigen recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med 1993;178(4):1321-1336.
23. Draghi M, Yawata N, Gleimer M, Yawata M, Valiante NM, and Parham P: Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I. Blood 2005;105(5):2028-2035.
24. Portales P, Reynes J, Pinet V, et al.: Interferon-alpha restores HIV-induced alteration of natural killer cell perforin expression in vivo. AIDS 2003;17(4):495-504.
25. Alter G, Suscovich TJ, Kleyman M, et al.: Low perforin and elevated SHIP-1 expression is associated with functional anergy of natural killer cells in chronic HIV-1 infection. AIDS 2006;20(11):1549-1551.
26. Mavilio D, Lombardo G, Benjamin J, et al.: Characterization of CD56-=CD16+natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci USA 2005;102(8):2886- 2891.
27. Zhang R, Xu J, Hong K, et al.: Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status. AIDS 2007;21(Suppl 8):S9-S17.
28. Fellay J, Shianna KV, Ge D, et al.: A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317(5840):944-947.
29. Biassoni R, Falco M, Cambiaggi A, et al.: Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 1995;182(2): 605-609.
30. Biassoni R, Cantoni C, Falco M, et al.: The human leukocyte antigen (HLA)-C-specific ''activatory'' or ''inhibitory'' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996;183(2):645-650.
31. Stewart CA, Laugier-Anfossi F, Vely F, et al.: Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci USA 2005;102(37):13224-13229.
32. Catalfamo M, Di Mascio M, Hu Z, et al.: HIV infectionassociated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc Natl Acad Sci USA 2008;105(50):19851-19856.
33. Perreau M, Pantaleo G, and Kremer EJ: Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells. J Exp Med 2008;205(12):2717-2725.
34. De Maria A, Fogli M, Costa P, et al.: The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol 2003; 33(9):2410-2418.
35. Harrison D, Phillips JH, and Lanier LL: Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II). J Immunol 1991;147(10):3459-3465.
36. Grzywacz B, Kataria N, and VernerisMR: CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases. Leukemia 2007;21(2): 356-359; author reply 359.
37. von Essen M, Bonefeld CM, Siersma V, et al.: Constitutive and ligand-induced TCR degradation. J Immunol 2004;173(1): 384-393.
38. Bonefeld CM, Haks M, Nielsen B, et al.: TCR down-regulation controls virus-specific CD8+T cell responses. J Immunol 2008;181(11):7786-7799.